OCT3 promoter haplotype is associated with metformin pharmacokinetics in Koreans
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
OCT3 promoter haplotype is associated with metformin pharmacokinetics in Koreans
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-13
DOI
10.1038/s41598-018-35322-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice
- (2016) Yoshiyuki Shirasaka et al. Drug Metabolism and Pharmacokinetics
- HGVS Recommendations for the Description of Sequence Variants: 2016 Update
- (2016) Johan T. den Dunnen et al. HUMAN MUTATION
- Allele frequency and genotype distribution of a common variant in the 3´-untranslated region of the SLC22A3 gene in patients with type 2 diabetes: Association with response to metformin
- (2016) Abdolkarim Mahrooz et al. Journal of Research in Medical Sciences
- The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin
- (2015) Jennifer E. Hibma et al. CLINICAL PHARMACOKINETICS
- Sp1 transcription factor: A long-standing target in cancer chemotherapy
- (2015) Carolina Vizcaíno et al. PHARMACOLOGY & THERAPEUTICS
- Taste of a Pill
- (2014) Nora Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Organic Cation Transporter OCTs (SLC22) and MATEs (SLC47) in the Human Kidney
- (2013) Hideyuki Motohashi et al. AAPS Journal
- Identification and functional characterization of novel MATE1 genetic variations in Koreans
- (2013) Tae Hee Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics
- (2013) Jae-Yong Chung et al. Pharmacogenetics and Genomics
- The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
- (2012) S L Stocker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Metformin pathways
- (2012) Li Gong et al. Pharmacogenetics and Genomics
- Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3
- (2012) L Chen et al. PHARMACOGENOMICS JOURNAL
- A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to Metformin
- (2011) J H Choi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Polymorphisms in Organic Cation Transporter 1 (OCT1) in Chinese and Japanese Populations Exhibit Altered Function
- (2010) L. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Selective Transport of Monoamine Neurotransmitters by Human Plasma Membrane Monoamine Transporter and Organic Cation Transporter 3
- (2010) H. Duan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
- (2010) Zhi-Jun Wang et al. Pharmacogenetics and Genomics
- Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin
- (2010) Ligong Chen et al. Pharmacogenetics and Genomics
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
- (2009) M. L. Becker et al. DIABETES
- Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin
- (2009) Ying Chen et al. Pharmacogenetics and Genomics
- Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
- (2009) Matthijs L. Becker et al. Pharmacogenetics and Genomics
- Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
- (2008) IS Song et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now